Pulsalys

Lyophitech is a manufacturer of innovative freeze-drying equipment tailored for the pharmaceutical sector and other industries such as food and microbiology. The company specializes in developing patented technologies that streamline and enhance freeze-drying processes, enabling clients to complete drying cycles more efficiently. By focusing on reducing operating time and costs, Lyophitech's equipment supports continuous operation and addresses common challenges associated with freeze-drying. With applications extending to probiotics and plant extracts, the company positions itself as a leader in advancing freeze-drying methodologies across various sectors.

Mecaware is a company focused on enhancing strategic autonomy through resource circularity and the intelligent management of material cycles. It specializes in battery recycling technology that recovers critical metals and rare earth elements, thereby promoting a sustainable supply chain for the battery industry. By providing innovative and eco-efficient industrial products and services, Mecaware facilitates the recycling of critical metals from end-of-life batteries and production scraps. This approach not only helps clients secure their supply of essential metals but also significantly reduces environmental impact, aligning with global sustainability goals.

Lys Therapeutics is a biotechnology company focused on developing therapies for patients with neurovascular and neurodegenerative disorders. The company is notable for its lead drug, Glunozumab, a monoclonal antibody that employs a novel mechanism of action. This drug hyperactivates both vascular and neuronal NMDA receptors, leading to off-target toxicity that can disrupt the blood-brain and blood-spinal cord barriers, resulting in neuronal excitotoxicity associated with conditions such as stroke and multiple sclerosis. Lys Therapeutics aims to address neuroinflammation and its effects on neurodegeneration through innovative biotherapies.